FIELD: biotechnology.
SUBSTANCE: group of inventions relates to a liposomal dosage form intended for transporting granzyme B into mammalian cells. The method for obtaining liposomes loaded with granzyme B protein includes obtaining a lipid bilayer dissolved in chloroform, dispersing it with a proteinase solution, shaking and evaporating, dispersing the resulting film with granzyme B, while to obtain a lipid bilayer, the components dissolved in a non-polar solvent are taken in the following molar ratio ranges: phosphatidylcholine (6 to 7): cholesterol (2 to 4): mPEG2000-DSPE (0.005 to 0.014). Also liposomes containing granzyme B and the use of liposomes to deliver granzyme B into a mammalian cell and initiate cytotoxic activity in it are disclosed.
EFFECT: group of inventions provides delivery of a biologically active form of granzyme B into a mammalian cell.
13 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOLIPOSOMAL FORM OF PHOTOSENSITISER | 2009 |
|
RU2410090C1 |
BINARY IMMUNOLIPOSOMAL NANOSYSTEM OF TARGETED DELIVERY TO CONNEXIN -43 POSITIVE TUMOUR CELLS | 2009 |
|
RU2422154C2 |
ANTITUMORAL AGENT ON BASIS OF IMMUNOPOLISOME BIOLOGICAL STRUCTURE, WAY OF ITS OBTAINING AND VECTORIAL DELIVERY IN CENTRAL NERVOUS SYSTEM AT TUMORAL PROCESS | 2007 |
|
RU2336901C1 |
PROAPOPTOSIS PROTEINS-CONTAINING THERAPEUTIC AGENTS | 2002 |
|
RU2319709C2 |
AGENT IMPROVING ANTI-CANCER EFFECT AND CONTAINING LIPOSOMAL AGENT CONTAINING OXALIPLATIN, AND ANTI-CANCER AGENT CONTAINING LIPOSOMAL AGENT | 2009 |
|
RU2492863C2 |
LIPOSOMAL COMPOSITIONS USED FOR DRUG DELIVERY | 2015 |
|
RU2757110C2 |
LIPOSOMAL COMPOSITIONS APPLICABLE FOR DRUG DELIVERY | 2005 |
|
RU2574926C2 |
MEANS FOR PHOTODYNAMIC THERAPY | 2016 |
|
RU2646834C1 |
COMPOSITION FOR INHIBITING GROWTH AND STIMULATION OF APOPTOSIS OF COLORECTAL CANCER CELLS | 2016 |
|
RU2644675C1 |
PHARMACEUTICAL COMPOSITION CONTAINING DOXORUBICIN AS PART OF PHOSPHOLIPID NANOPARTICLES USING SELECTIVE DNA APTAMER MOLECULES FOR TARGETED TRANSPORT TO TUMOR CELLS | 2021 |
|
RU2794798C1 |
Authors
Dates
2023-05-29—Published
2021-04-19—Filed